Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
Eli Lilly and Company
Juan P Frias; Stanley Hsia; Sarah Eyde; Rong Liu; Xiaosu Ma; Manige Konig; Christof Kazda; Kieren J Mather; Axel Haupt; Edward Pratt; Deborah Robins